VeriSeq™ NIPT Solution v2: Expect the extraordinary in prenatal screening

18 April 2023

VeriSeq NIPT Solution v2. A workflow that works with you. Ease: A simple, easy-to-use, automated system that seamlessly integrates into your lab’s current workflow and flexes with your lab’s growing needs. Accuracy: An in-lab IVD NIPT screening assay solution that delivers high accuracy with greater than or equal to 99.9% sensitivity and specificity. Results you and your clinicians can trust. Speed: Results in approximately 26 hours with only 2 hours of hands-on time means clinicians and their expecting families get answers faster. For In Vitro Diagnostics Use. Not available in all regions and countries. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illu... Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina

Share this article on